Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.
Gazzerro
Elisabetta
E
University of Genoa, G. Gaslini Institute, Largo G. Gaslini 5, I-16147 Genoa, Italy. elisabettagazzerro@ospedale-gaslini.ge.it
Assereto
Stefania
S
Bonetto
Andrea
A
Sotgia
Federica
F
Scarfì
Sonia
S
Pistorio
Angela
A
Bonuccelli
Gloria
G
Cilli
Michele
M
Bruno
Claudio
C
Zara
Federico
F
Lisanti
Michael P
MP
Minetti
Carlo
C
D000818:Animals; D001897:Boronic Acids / Q000494:pharmacology; D000069286:Bortezomib; D004195:Disease Models, Animal; D049030:Dystroglycans / Q000378:metabolism; D005070:Evans Blue / Q000494:pharmacology; D005786:Gene Expression Regulation; D006023:Glycoproteins / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D020388:Muscular Dystrophy, Duchenne / Q000378:metabolism* / Q000628:therapy; D009154:Mutation; D061988:Proteasome Inhibitors; D011719:Pyrazines / Q000494:pharmacology; D049031:Sarcoglycans / Q000378:metabolism; D025801:Ubiquitin / Q000737:chemistry
D001897:Boronic Acids; D006023:Glycoproteins; D061988:Proteasome Inhibitors; D011719:Pyrazines; D049031:Sarcoglycans; D025801:Ubiquitin; D049030:Dystroglycans; D005070:Evans Blue; D000069286:Bortezomib